Skip to main content

HPV Rears its Cancerous Head

Premium

There are 130 unique types of Human Papillomavirus, several kinds of which are known to cause cervical cancer. Researchers are now finding, however, that HPV is also causing head and neck cancers in many regions of the world, according to Ohio State University’s Maura Gillison. Head and neck cancers are driven by environmental conditions such as tobacco use, Gillison said at last week’s AMP conference. Researchers are also currently studying the role of the oral microbiome in these diseases, she added. But incidences of HPV-positive head and neck cancers are increasing. Patients suffering from head and neck cancers are getting younger and the risk factors are changing from alcohol and tobacco use to oral sex and marijuana use (which is thought to be immunosuppressive), Gillison said. However, the good news is that patients with HPV-positive head and neck cancer have a 50 percent reduction in risk of death from HPV-negative cancer. The relative survival for HPV-positive patients is also independent of therapy, leading to the conclusion that therapy for these patients can be de-intensified, Gillison said. She and her team are trying to develop and assay to be used in clinical labs to determine whether tumors are HPV-positive or –negative.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.